ArticleToxics2026
Integrated Assessment of Soil Contamination and Ecological and Human Health Risks at the Morava Thermal Power Plant Complex: A Three-Year Case Study.
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This three-year case study integrated the results of annual soil-monitoring campaigns conducted in 2022-2024 at 17 predefined locations within and immediately surrounding the Morava Thermal Power Plant Complex, Serbia. We analyzed surface soil samples (0-30 cm) for physical and chemical properties, metals and metalloids, and selected organic pollutants. Contaminant concentrations were evaluated relative to national regulatory thresholds, while potential ecological risk and outdoor worker human health risk were assessed using the potential ecological risk index (RI), Hazard Index (HI), and total carcinogenic risk (TCR). Soil properties and total contaminant concentrations varied considerably among the monitored locations. Regulatory classification identified Ni and Cd as the most widespread concerns. Ni exceeded the applicable limit value at all 17 locations in each campaign, including three remediation-value exceedances in 2022 and one in 2024. Cd exceeded the limit value at 17, 11, and 16 locations in 2022, 2023, and 2024, respectively, without exceeding the remediation value. RI ranged from 210.02 to 963.08, indicating moderate to very high potential ecological risk, and was driven primarily by Cd and Hg. Aggregate HI values ranged from 0.211 to 0.484 and remained below the screening threshold of 1 at all locations. In contrast, TCR ranged from 5.98 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.